- Dysport®is a prescription injection for temporary improvement in the look of moderate to severe glabellar lines – the first new muscle relaxant approved in China for eight years
Zug, Switzerland, April 23, 2026 – Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026.
Cetaphil on a mission to help the 70% of Americans that self-diagnose as having sensitive skin1 with first-hand access to experts and science-driven recommendations.
Results 96 - 100 of 156
Page 20 of 32
Confirm navigation
You are about to leave the Galderma global site. Are you sure you want to leave this page?